0QCV.LSE AbbVie Inc

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
21.1x
P/B
-
ROE
-
Dividend yield
0.04%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0QCV.LSE undervalued?

Graham number

The Graham number of AbbVie Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AbbVie Inc fundamental analysis

No fundamental analysis for AbbVie Inc yet.

AbbVie Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AbbVie Inc

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung canc…

Full company profile